MA
INSIDER · REGN · REGENERON PHARMACEUTICALS, INC. · CO-CHIEF SCIENTIFIC OFFICER
MURPHY ANDREW J
Every open-market transaction filed under this name, Oct 14 to Oct 14.
Filings
27
0 buys · 27 sells
Bought
—
open market, at cost
Sold
$3.2M
includes scheduled sales
Buys since
—
no current price on file
Filings
| Traded | Ticker | Company | Role | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|---|---|
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 50 | $781.47 | $39K | +1.2% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 463 | $780.63 | $361K | +1.3% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 380 | $779.59 | $296K | +1.4% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 454 | $778.64 | $354K | +1.6% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 38 | $777.76 | $30K | +1.7% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 66 | $776.31 | $51K | +1.9% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 376 | $775.46 | $292K | +2.0% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 121 | $774.48 | $94K | +2.1% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 224 | $773.40 | $173K | +2.2% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 211 | $772.56 | $163K | +2.4% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 283 | $771.56 | $218K | +2.5% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 12 | $770.20 | $9K | +2.7% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 127 | $769.30 | $98K | +2.8% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 105 | $768.33 | $81K | +2.9% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 192 | $767.39 | $147K | +3.0% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 279 | $766.47 | $214K | +3.2% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 271 | $765.39 | $207K | +3.3% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 219 | $764.40 | $167K | +3.4% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 25 | $763.76 | $19K | +3.5% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 55 | $762.57 | $42K | +3.7% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 27 | $761.36 | $21K | +3.9% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 74 | $760.65 | $56K | +4.0% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 14 | $759.96 | $11K | +4.1% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 24 | $758.16 | $18K | +4.3% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 16 | $757.68 | $12K | +4.4% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 35 | $755.91 | $26K | +4.6% |
| Oct 14 | REGN | REGENERON PHARMACEUTICALS, INC. | Co-Chief Scientific Officer | Sell | 6 | $753.76 | $5K | +4.9% |
"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.